Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senators Seek “Fresh” Ideas To Fight Health Fraud From Stakeholders

This article was originally published in The Pink Sheet Daily

Executive Summary

An open letter to the “health care community” from a bipartisan group of senators on the Finance Committee asks for white papers offering suggestions on the best ways to combat “the multi-billion dollar problem” of waste, fraud and abuse in Medicare and Medicaid.

You may also be interested in...



HHS OIG To Investigate Drug Shortages, Rebates, Other Pharma Issues In 2013

A number of topical issues will be investigated by the HHS Office of Inspector General, according to its work plan for fiscal year 2013. Pharma industry issues are concentrated in the Medicare and Medicaid space.

McKesson Closer To Resolving Multi-Year AWP Legal Saga With $190M Federal Settlement

Wholesale drug distributor McKesson settles charges that it reported inflated average wholesale prices (AWPs) for a large number of branded prescription pharmaceuticals, leading to extensive overpayments by the Medicaid program.

Nursing Home Overprescribing: CMS Urges Voluntary Remedies, Withholds Regulation

CMS will not implement an earlier regulatory proposal requiring that consultant pharmacists maintain independence from long-term care facilities or drug firms at this point.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS074187

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel